ER+/PgR-and ER-/PgR+ tumors are biologically and clinically distinct groups of breast cancer that may require different treatment strategies with ER-/PgR+ exhibiting more aggressive behavioral characteristics.
No takes yet. Share an insight, caveat, or question.
Rakha et al. (2007) studied this question.